<DOC>
	<DOCNO>NCT01882426</DOCNO>
	<brief_summary>Assess standardize care-path feature objective evaluation disease activity time-bound algorithm superior usual step-care treatment ulcerative colitis .</brief_summary>
	<brief_title>Care Path Management Ulcerative Colitis</brief_title>
	<detailed_description>Step-care base symptomatic response remain overwhelming algorithm choice clinical practice . Many subject receive infliximab last resort , subject ill fail repeat attempt corticosteroid induction therapy . Although situation far ideal , change entrench physician behavior require compelling evidence Step-care result inferior outcome earlier introduction effective therapy . Based consideration , perform cluster randomization trial 40 gastroenterology practice randomly assign treatment algorithm feature early use combination therapy , treatment intensification guide objective assessment inflammation use remission therapeutic goal conventional Step-care approach .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>Females child bear potential must negative serum pregnancy test prior randomization , must use hormonal ( oral , implantable injectable ) barrier method birth control throughout study . Females unable bear child must documentation source record Documented diagnosis UC Mayo Clinic Score ( MCS ) â‰¥6 baseline Mayo Endoscopy Score &gt; 2 . Either elevate serum Creactive protein ( CRP ) ( Upper Level Normal ( ULN ) accord local laboratory result ) elevate fecal calprotectin ( &gt; 250 mg/kg ) concentration . Requires sigmoidoscopic evaluation baseline ( standard care ) Written informed consent must obtain document . Ability subject participate fully aspects clinical trial opinion investigator . Previous failure TNF antagonist therapy Received investigational drug past 30 day 5 halflives , whichever longer . Pregnant lactating woman . Any condition ( e.g. , history alcohol substance abuse ) opinion investigator , may interfere subject 's ability comply study procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>CONSTRUCT</keyword>
	<keyword>Cluster randomization control trial</keyword>
	<keyword>Gastroenterology practice North America</keyword>
</DOC>